Why is Inovio Pharmaceuticals stock plunging today?

More in Finance

• Wall Street stocks in relief rally after heavy AI-related selloff

  Investor anxiety eased slightly as semiconductor and tech leaders rebounded from a multi-trillion-dollar wipeout sparked by Democratic election wins and proposed restrictions on data centers. While the turnaround offered domestic stability, major U.S. benchmarks still notched weekly declines amid persistent regulatory concerns. Stronger-than-expected American jobs data also lifted Treasury yields and the dollar, setting the domestic recovery apart from ongoing slumps overseas.

  3 min read
• Quick Mart IPO Draws Strong Demand as Kenyan Listings Pick Up

  Kenya's equity market revival gained momentum after investor bids exceeded the available shares in the nation's second public offering of the year by nearly 23%. The sale provides a rare domestic exit for private equity backers Adenia Partners and the retailer's founder rather than raising capital for the supermarket chain. Trading is slated to begin on the Nairobi Securities Exchange on November 12.

  2 min read
• vVardis targets IPO at up to $24 per share

  The company is preparing its market debut with a specific target price ceiling established for prospective investors. This pricing framework sets the upper limit for shares entering the public market, providing an initial baseline for market demand. The move signals the company's intention to finalize its capital-raising efforts through public trading channels.

  1 min read